STOCK TITAN

argenx to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
argenx, a global immunology company, will participate in investor conferences in March 2024 to discuss their commitment to improving the lives of people with severe autoimmune diseases.
Positive
  • None.
Negative
  • None.


February 26, 2024

Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following investor conferences in March:

  • TD Cowen 44th Annual Health Care Conference. Fireside chat on Monday, March 4, 2024 at 11:10 a.m. ET in Boston, MA.
  • Leerink Global Biopharma Conference. Fireside chat on Monday, March 11, 2024 at 2:40 p.m. ET in Miami, FL.
  • Barclays Global Healthcare Conference. Fireside chat on Tuesday, March 12, 2024 at 3:35 p.m. ET in Miami, FL.

Additional information regarding these events will be available on the Investors section of the argenx website at argenx.com/investors.

About argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker in the U.S., Japan, Israel, the EU, the UK, Canada and China. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, Twitter, and Instagram HYPERLINK "http://www.instagram.com/argenxglobal".

For further information, please contact:

Media:

Ben Petok
bpetok@argenx.com

Investors:

Alexandra Roy (US)
aroy@argenx.com

Lynn Elton (EU)
lelton@argenx.com


FAQ

When will argenx participate in the TD Cowen 44th Annual Health Care Conference?

argenx will participate in the TD Cowen 44th Annual Health Care Conference on Monday, March 4, 2024, at 11:10 a.m. ET in Boston, MA.

Where will the Fireside chat be held during the Leerink Global Biopharma Conference?

The Fireside chat during the Leerink Global Biopharma Conference will be held on Monday, March 11, 2024, at 2:40 p.m. ET in Miami, FL.

What time is the Fireside chat scheduled for during the Barclays Global Healthcare Conference?

The Fireside chat during the Barclays Global Healthcare Conference is scheduled for Tuesday, March 12, 2024, at 3:35 p.m. ET in Miami, FL.

Where can additional information about the events be found?

Additional information about these events can be found on the Investors section of the argenx website at argenx.com/investors.

argenx SE American Depositary Shares

NASDAQ:ARGX

ARGX Rankings

ARGX Latest News

ARGX Stock Data

23.07B
58.81M
0%
55.84%
2.03%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
Breda

About ARGX

Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.